Indivior Pharmaceuticals (INDV) Receivables (2021 - 2026)
Indivior Pharmaceuticals' Receivables was $271 million in Q2 2026, up 12.9% from $240 million a year earlier but down 0.7% from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Receivables (2021 - 2026) Analysis & Trends
At the end of FY2025, Receivables at Indivior Pharmaceuticals came in at $255 million, down 0.4% from FY2024.
- Receivables shows a four-year compound annual growth rate of 6.0% (FY2021 to FY2025).
- In earlier years, Receivables was $256 million in FY2024 (+0.4%), $255 million in FY2023 (+15.9%), $220 million in FY2022 (+8.9%) and $202 million in FY2021.
- Quarterly Receivables has moved between $202 million (Q4 2021) and $273 million (Q1 2026) over five years.
- Compared with a year earlier, Receivables was higher in three of the last four quarters, with growth averaging 6.3%.
- Per Business Quant data, INDV's Receivables in the three quarters before Q2 2026 was $273 million (Q1 2026), $255 million (Q4 2025) and $259 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Indivior Pharmaceuticals | 4.13 Bn | 3.10 Bn | 294.00 Mn | 271.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 271.00 Mn |
| Mar 31, 2026 | 273.00 Mn |
| Dec 31, 2025 | 255.00 Mn |
| Sep 30, 2025 | 259.00 Mn |
| Jun 30, 2025 | 240.00 Mn |
| Mar 31, 2025 | 243.00 Mn |
| Dec 31, 2024 | 256.00 Mn |
| Dec 31, 2023 | 255.00 Mn |
| Dec 31, 2022 | 220.00 Mn |
| Dec 31, 2021 | 202.00 Mn |
API Access
Indivior Pharmaceuticals Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();